ArticleFrontiers in pharmacology2021

Huangqi Shengmai Yin Ameliorates Myocardial Fibrosis by Activating Sirtuin3 and Inhibiting TGF-β/Smad Pathway.

Jianheng Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.